Our

Technology

We are building multifunctional next-generation biologics for cancer therapy, using a modular approach to drug candidate assembly.

Core 1

1D
Core Library

Core 2

1D
Core Library

Binders

1D - 3D
Binder Library

Payloads

1D - 2D Linker-Payload

Assembly 2

Drug Candidate

Assembly 1

Drug Candidate

Assembly 3

Drug Candidate

001

LiliumX™ Platform

We rapidly combine components of proprietary format, binder and payload libraries to construct drug candidates with bespoke geometries and target combinations. Our multidimensional LiliumX™ Platform readily generate libraries of bispecific antibody-drug conjugates, multivalent multispecifics, or any other therapeutic feature.

4 heatmaps
002

Iterative Screening

From a vast, untapped space of potential components and target combinations, our platform can rapidly identify the most potent drug candidates through iterative screening and design—leveraging our 1-day design process.

003

New Biology

With this, we are able to create and find drugs that can’t otherwise be identified—unlocking the next generation of multifunctional antibody therapeutics.

A diagram of a heatmap with 2 lines connecting to 2 different antibody assemblies

1 Day Assembly

5D 
Design

Iterative Discovery

Contact Us

United States

Valink Therapeutics Inc
50 Milk Street,
16th floor,
Boston,
MA 02109

United Kingdom

Valink Therapeutics Ltd
Imperial I-Hub,
84 Wood Lane,
London,
W12 0BZ

a tick

Message sent successfully.

a cross

Oops, something happened. Please try again.

United Kingdom

Valink Therapeutics Ltd
Imperial I-Hub,
84 Wood Lane,
London,
W12 0BZ
United States

Valink Therapeutics Inc
50 Milk St.,
16th floor,
Boston,
MA 02109